Home
Approvals
Therapeutic Areas
Cell & Gene Therapy
Dashboards
Insights
Emerging
Briefs
Conferences
Pricing
Login
Logout
Home
/
Therapeutic Areas
/
Neurology
Neurology Drugs
2 FDA-approved drugs
Recent Approvals
WAINUA
EPLONTERSEN SODIUM
the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults...
2023-12-21
AstraZeneca
RELGAABI
GABAPENTIN
RELGAABI is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the ...
2016-02-18
SCIEGEN PHARMS
Top Companies
AstraZeneca
1
SCIEGEN PHARMS
1
Drug Classes
Transthyretin-directed RNA Interaction
1
Quick Stats
Total Drugs
2
Companies
2
Drug Classes
1
Latest Approval
2023-12-21